Paratiroid Adenomlarının Cerrahi Tedavisinde Klinik Deneyimlerimiz

Öz

Günümüzde gelişen sağlık koşulları ile rutin olarak serum kalsiyumunun ölçülmesi sonucu, aşikar veya subklinik hiperparatiroidi en yaygın endokrin hastalıklardan biri haline gelmiştir. Parathormonun sıklıkla bir, bazen de birden fazla paratiroid bezindeki adenomlardan aşırı salınması en sık görülen hiperparatiroidi nedenidir. Görüntüleme ve cerrahi tekniklerdeki gelişmelere bağlı günümüzde paratiroid cerrahisi minimal invazif teknikler ile, etkin ve düşük komplikasyon oranları ile yapılmaktadır. Bu çalışmada paratiroid adenomu tanısıyla kliniğimizde ameliyat edilen hastaların sonuçlarını literatür eşliğinde sunmayı amaçladık.

Anahtar Kelimeler

• Hiperparatiroidi,Paratiroid adenomu,Minimal invazif paratiroid cerrahisi

Our Clinical Experiencein the Surgical Treatment of Parathyroid Adenomas

Öz

Clinical or subclinical hyperpathyroidism has recently becom eone of the most common endocrine disorder due to developing health conditions. Oversecretion of parathormone, usually from one but rarely from two or more parathyroid glands is the leading couse of hyperparathyroidism. Today, parathyroid surgery is performed with minimally invasive techniques, with effective and low complication rates due to advances in imaging and surgical techniques. We aimed to present the results of patients who underwent surgery in our clinic with the diagnosis of parathyroid adenoma in this study.

Anahtar Kelimeler

• Hyperparathyroidism,Parathyroid adenoma,Minimally invasive parathyroid surgery

Kaynakça

1. 1. Bilezikian JP, Khan AA, Potts JT Jr. Third international workshop on the management of asymptomatic primary hyperparathyroidism. Guide-lines for the management of asymptomatic primary hyperparathyroidism: summary statement from third international workshop. J Clin Endocrinol Metab. 2009;94:335-9.
2. 2. Elgazzar A. Editor from The pathophysiologic basis of nuclear medicine. Berlin, Springer, 2001. Chap 7, Parathyroid gland p.141-6.
3. 3. Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, et al. Prospective localisation and radioguided parathyroid surgery. J Nucl Med. 2003;44:1443-58.
4. 4. DeLellis RA, Mazzaglia P, Mangray S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med. 2008;132(8):1251-62.
5. 5. DeLellis RA. Parathyroid carcinoma: an overwiev. Adv Anat Pathol. 2005;12(2):53-61.
6. 6. Hopkins RC, Reading CC. Thyroid and parathyroid imaging. Semin Ultrasound CT MR. 1995;16(4):279-95.
7. 7. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472-8.
8. 8. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res. 2002;17:18-23.

9. 9. Dackiw APB, Susman JJ, Fritsche HA, at al. Relative contributions of Tc99m sestamibi scintigraphy, intraoperative gamma probe detection and rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg. 2000;136:550-7.
10. 10. Palestro CJ, Tomas MB, Tronco GG. Radionuclide imaging of the parathyroid glands. Semin Nucl Med 2005;35:266-76.
11. 11. Giordano A, Rubello D, Casara D. New trends in parathyroid scintigraphy. Eur J Nucl Med. 2001;28:1409-20.
12. 12. Rubello D, Casara D, Pelizzo MR. Symposium on parathyroid localisation: Optimisation of peroperative procedures. Nucl Med Commun. 2003;24:133-140.
13. 13. Norman J, Chheda H. Minimally invasive parathyroidectomy facilitated by intraoperativ enuclear mapping. Surgery. 1997;122(6):998-1003.
14. 14. Murphy C, Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery. 1999;126(6):1023-8.
15. 15. Witteveev JE, vanThiel S, Romijn JA, Hamdy NA. Hungry bone syndrome: still a challange in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. 2013 Eur J Endocrinol.